Showing results (21-30 of 40) with videos related to
Sort By:
Pageof 4
Journal of Neurology|October 21, 2016
Impulse control behaviors and subthalamic deep brain stimulation in Parkinson diseaseAristide Merola, Alberto Romagnolo, Laura Rizzi, et al.Movement Disorders : Official Journal of the Movement Disorder Society|May 4, 2011
The modified bradykinesia rating scale for Parkinson's disease: reliability and comparison with kinematic measuresDustin A Heldman, Joseph P Giuffrida, Robert Chen, et al.Neurology and Therapy|March 12, 2020
Current Directions in Deep Brain Stimulation for Parkinson's Disease-Directing Current to Maximize Clinical BenefitAristide Merola, Alberto Romagnolo, Vibhor Krishna, et al.Neurology|February 27, 2025
Clinical Reasoning: Juvenile-Onset Dopa-Responsive Dystonia-Until It Isn'tNathaly Chinchihualpa Paredes, Pasquale Maria Pecoraro, Syed A Zaidi, et al.Parkinsonism & Related Disorders|April 5, 2020
Thalamic Deep Brain Stimulation for tremor: The critical role of intraoperative testingAbhimanyu Mahajan, Alexander Bader, Lily L Wang, et al.Journal of Neurology|March 8, 2018
Deep brain stimulation in uncommon tremor disorders: indications, targets, and programmingCarlo Alberto Artusi, Ashar Farooqi, Alberto Romagnolo, et al.Movement Disorders : Official Journal of the Movement Disorder Society|October 4, 2012
Psychogenic facial movement disorders: clinical features and associated conditionsAlfonso Fasano, Anabela Valadas, Kailash P Bhatia, et al.Movement Disorders : Official Journal of the Movement Disorder Society|September 29, 2011
Differential response of speed, amplitude, and rhythm to dopaminergic medications in Parkinson's diseaseAlberto J Espay, Joe P Giuffrida, Robert Chen, et al.Neurology|April 6, 2011
Methylphenidate for gait impairment in Parkinson disease: a randomized clinical trialA J Espay, A K Dwivedi, M Payne, et al.Journal of the Neurological Sciences|January 30, 2017
Conversion to carbidopa and levodopa extended-release (IPX066) followed by its extended use in patients previously taking controlled-release carbidopa-levodopa for advanced Parkinson's diseaseJames Tetrud, Paul Nausieda, David Kreitzman, et al.Pageof 4